What does REMEDUS do?

REMEDUS is registered with the CBE as active in: Groothandel in farmaceutische producten. Private Limited, started on 21 December 1995, 1 establishment.

What is the address of REMEDUS?

The registered office of REMEDUS is located at Satenrozen 19, 2550 Kontich.

Is REMEDUS still active?

Yes. According to the CBE (30 October 2026) REMEDUS is active, legal situation “Normale toestand”, started on 21 December 1995.

Is REMEDUS registered on Peppol?

Yes, REMEDUS is registered on the Peppol network with ID 0208:0456716679.

What is the enterprise number of REMEDUS?

The enterprise number of REMEDUS is BE0456716679.

When was REMEDUS founded?

REMEDUS was founded on 21 December 1995.

Who are the directors of REMEDUS?

According to the 2025 annual accounts, the directors of REMEDUS are: Julie Steyt, Medeco NV.

Is REMEDUS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 December 1995; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did REMEDUS make in 2025?

REMEDUS posted a profit after taxes of € 736,403 in financial year 2025.

What is the revenue of REMEDUS?

In its most recent annual accounts (2025), REMEDUS reported revenue of € 16,697,127.

How much does an employee at REMEDUS earn?

The average wage cost per full-time employee at REMEDUS was € 81,200 in 2025: staff costs of € 5.2 million for 64.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does REMEDUS have?

According to the 2025 annual accounts, REMEDUS has 64.6 full-time equivalents (FTE).

REMEDUS (Private Limited) - Kontich - BE0456716679

Dossier REMEDUS, printed on 30 October 2026 from databakkes.be/en/0456716679/remedus. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Board fully replaced NBB

No director from three years ago is still active according to annual account 2025.

Financials

Financial year 2025

REMEDUS from Kontich, company number BE0456716679, closed financial year 2025 with a result of € 736,403 after tax. For that financial year REMEDUS recorded revenue of € 16.7 million and equity of € 463,351. Compared with financial year 2024, the result moved from € 140,636 to € 736,403. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Healthy

€ 463,351

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 736,403

▲ € 595,767 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 437,125

▼ 71% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 800,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

64.6

▲ 3.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 3.9 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 5.2 million

▲ 12% vs 2024

€ 81,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 45,389

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2 million

▲ 9% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 71 days on average.

Taxes and wages

€ 697,980

▼ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 12,988,982 Revenue 2022: € 12,988,982 First fiscal year in the series	€ 14,231,465 Revenue 2023: € 14,231,465 ▲ 10% vs 2022 (€ 12,988,982) Favourable step	€ 15,725,412 Revenue 2024: € 15,725,412 ▲ 10% vs 2023 (€ 14,231,465) Favourable step	€ 16,697,127 Revenue 2025: € 16,697,127 ▲ 6% vs 2024 (€ 15,725,412) Favourable step	▲ 6%
Profit after taxes	€ 1,641,768 Profit after taxes 2022: € 1,641,768 First fiscal year in the series	€ 538,870 Profit after taxes 2023: € 538,870 ▼ 67% vs 2022 (€ 1,641,768) Unfavourable step	€ 140,636 Profit after taxes 2024: € 140,636 ▼ 74% vs 2023 (€ 538,870) Unfavourable step	€ 736,403 Profit after taxes 2025: € 736,403 ▲ € 595,767 vs 2024 (€ 140,636) Favourable step	▲ € 595,767
Equity	€ 1,447,442 Equity 2022: € 1,447,442 First fiscal year in the series	€ 1,186,313 Equity 2023: € 1,186,313 ▼ 18% vs 2022 (€ 1,447,442) Unfavourable step	€ 526,948 Equity 2024: € 526,948 ▼ 56% vs 2023 (€ 1,186,313) Unfavourable step	€ 463,351 Equity 2025: € 463,351 ▼ 12% vs 2024 (€ 526,948) Unfavourable step	▼ 12%
Total debts	€ 3,677,290 Total debts 2022: € 3,677,290 First fiscal year in the series	€ 4,144,635 Total debts 2023: € 4,144,635 ▲ 13% vs 2022 (€ 3,677,290) Unfavourable step	€ 4,810,117 Total debts 2024: € 4,810,117 ▲ 16% vs 2023 (€ 4,144,635) Unfavourable step	€ 3,784,375 Total debts 2025: € 3,784,375 ▼ 21% vs 2024 (€ 4,810,117) Favourable step	▼ 21%
Cash	€ 1,509,881 Cash 2022: € 1,509,881 First fiscal year in the series	€ 1,769,943 Cash 2023: € 1,769,943 ▲ 17% vs 2022 (€ 1,509,881) Favourable step	€ 1,523,759 Cash 2024: € 1,523,759 ▼ 14% vs 2023 (€ 1,769,943) Unfavourable step	€ 437,125 Cash 2025: € 437,125 ▼ 71% vs 2024 (€ 1,523,759) Unfavourable step	▼ 71%
Retained profit	€ 1,428,850 Retained profit 2022: € 1,428,850 First fiscal year in the series	€ 1,167,721 Retained profit 2023: € 1,167,721 ▼ 18% vs 2022 (€ 1,428,850) Unfavourable step	€ 508,356 Retained profit 2024: € 508,356 ▼ 56% vs 2023 (€ 1,167,721) Unfavourable step	€ 444,759 Retained profit 2025: € 444,759 ▼ 13% vs 2024 (€ 508,356) Unfavourable step	▼ 13%
Dividend	€ 700,000 Dividend 2022: € 700,000 First fiscal year in the series	€ 800,000 Dividend 2023: € 800,000 ▲ 14% vs 2022 (€ 700,000) Unchanged	€ 800,000 Dividend 2024: € 800,000 Unchanged (€ 800,000) Unchanged	€ 800,000 Dividend 2025: € 800,000 Unchanged (€ 800,000) Unchanged
Bank debt	€ 40,210 Bank debt 2022: € 40,210 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 40,210) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 5,124,732 Balance sheet total 2022: € 5,124,732 First fiscal year in the series	€ 5,330,948 Balance sheet total 2023: € 5,330,948 ▲ 4% vs 2022 (€ 5,124,732) Unchanged	€ 5,337,065 Balance sheet total 2024: € 5,337,065 Unchanged (€ 5,330,948) Unchanged	€ 4,247,726 Balance sheet total 2025: € 4,247,726 ▼ 20% vs 2024 (€ 5,337,065) Unchanged	▼ 20%
Employees (FTE)	51.7 Employees (FTE) 2022: 51.7 First fiscal year in the series	57.7 Employees (FTE) 2023: 57.7 ▲ 6 vs 2022 (51.7) Unchanged	60.8 Employees (FTE) 2024: 60.8 ▲ 3.1 vs 2023 (57.7) Unchanged	64.6 Employees (FTE) 2025: 64.6 ▲ 3.8 vs 2024 (60.8) Unchanged	▲ 3.8

Key figures of REMEDUS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to REMEDUS?

What happened at REMEDUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Medeco NV stepped down as director. NBB
Jul 7, 2026 New annual accounts for financial year 2025: profit of € 736,403 (▲ € 595,767 vs 2024). Source: NBB ↗
2024 Julie Steyt became a director. NBB
2021 Medeco NV became a director. NBB
Jan 5, 1996 New establishment in Kontich. KBO
Dec 21, 1995 Start of the company according to the CBE. KBO

In short

From € 1.6 million profit in 2022 to € 736,403 profit in 2025.

Paid € 1 million in corporate taxes since 2022.

Best year ever: 2022, with € 1.6 million profit.

Paid out € 3.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

MEDECO 100%

The stake of MEDECO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

REMEDUS

Behind REMEDUS is Julie Steyt. The shares are held by MEDECO (100%).

Directors

According to the 2025 annual accounts

Julie Steyt

Director

Also active at: MEDECO

since 2024

Medeco NV

Director · represented by Marcia Luijendijk

since 2021 · until 2027

Shareholders

MEDECO

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Satenrozen 19

2550 Kontich

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MEDECO same network

€ 5.7 million revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0456.716.679

VAT number

BE 0456.716.679

Registered office

Satenrozen 19, 2550 Kontich

Names & denominations

REMEDUS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 December 1995

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Groothandel in farmaceutische producten

Groothandel in farmaceutische en medische artikelen

Activiteiten op het gebied van voeding

Overige activiteiten i.v.m. gezondheidszorg, n.e.g.

Overige menselijke gezondheidszorg, n.e.g.

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

REMEDUS

Warning lights

Financials

What happened to REMEDUS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions